The UBE3A gene helps nerve cells manage and recycle proteins so the brain can develop and work in an organized way. If it is missing or not working properly, especially the active copy in parts of the brain, it can lead to Angelman syndrome, which often causes developmental delay, limited speech, balance problems, and seizures. Some extra activity of this gene has also been linked to a higher chance of certain autism-related features. UBE3A is best known through research on Angelman syndrome rather than celebrity attention.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, which are the parts of cells that do much of the work. Other genes are used mainly to control when certain processes happen, where they take place, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
UBE3AGene function
What if the gene works
The UBE3A gene helps cells label certain proteins so they can be removed at the right time. In the brain, this supports nerve cell signaling, learning, memory, and early development.
Risk
What if the gene does not work
When the UBE3A gene does not work properly, the well-known effect is Angelman syndrome, usually when the maternal copy is affected. Milder or more severe variants can influence when symptoms appear and how speech, learning, movement, and seizures are affected.
Treatment
What does that mean for your treatment
No UBE3A-specific treatment or management approach is currently established; care is based on symptoms, such as seizure control and developmental support. Research is studying ways to restore UBE3A activity, including antisense treatments that aim to unsilence the working copy of the UBE3A gene.
Conditions associated with UBE3A
Gene function
What if the gene works
Your cells constantly sort, use, and recycle proteins to stay in balance. The UBE3A gene supports this process by helping place small tags on selected proteins, especially in nerve cells. Understanding the UBE3A gene’s function helps you see how your cells keep daily activity organized.
Inside your cells, the UBE3A gene adds small protein tags called ubiquitin to selected proteins. These tags help the cell decide whether a protein should be recycled, moved, or have its activity adjusted.
By controlling which proteins stay active and which are cleared away, the UBE3A gene helps keep the cell’s protein mix in balance. This steady turnover supports routine cell work from growth to signaling.
In nerve cells, the UBE3A gene helps manage proteins used at the connections that pass messages from one cell to another. This supports smooth brain signaling and is a key part of how the UBE3A gene works in brain cells.
What is a variant?
A genetic variant is a minor change in a gene's DNA sequence. These changes are common and help account for normal differences among people, such as appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In nerve cells, many variants in the UBE3A gene reduce or silence the copy inherited from the mother, showing how variants in the UBE3A gene affect protein function. Some variants stop the protein from being made, while others alter its shape so it is unstable or cannot tag other proteins for breakdown. Milder variants may leave some activity, but more severe variants can remove nearly all function. In Angelman syndrome, this can influence how early features appear and their extent.
How variants are linked to conditions
Pathogenic variants in the UBE3A gene are a well-established cause of Angelman syndrome, especially when the affected copy is the one inherited from the mother. This UBE3A gene and Angelman syndrome link is used to confirm the diagnosis in the right clinical setting. Extra active copies involving the UBE3A gene are also associated with a higher chance of developmental differences, including autism, intellectual disability, and seizures.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct impact on health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For UBE3A, risk is mainly shaped by the specific genetic change and whether it affects the active copy inherited from the mother. Family history can raise the chance in some families, especially when a parent carries a UBE3A change or an imprinting change. Lifestyle and environmental factors are not known to meaningfully change this genetic risk.
Inheritance of UBE3A variants
For families learning how variants of the UBE3A gene are inherited, the key point is parent of origin. UBE3A-related Angelman syndrome follows an inherited pattern called autosomal dominant with genomic imprinting, which means a disease-causing variant usually leads to the condition only when it is passed on by the mother. A woman carrying the variant has a 50% chance of passing it to each child, while a father can pass on the same variant without it usually causing Angelman syndrome in that child. Some cases happen for the first time in a child and are not inherited from either parent.
What does my UBE3A result mean for my family?
For UBE3A, what it means for family members depends a lot on which parent passed on the changed gene copy. A mother who carries the change can have children affected by Angelman syndrome, while a father may carry the same change without symptoms and still pass it on within the family. Close relatives may sometimes also carry the change, and some cases happen for the first time in one child rather than being inherited from a parent.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for UBE3A variants usually analyzes DNA from a blood or saliva sample. Labs may use sequencing to look for small changes in the UBE3A gene and other methods to check for missing or extra pieces, which can help clarify whether a variant is present.
When should I consider getting a genetic test?
Consider genetic testing if a child has signs of Angelman syndrome, such as major speech delay, trouble with balance or walking, seizures, and developmental delay, or if this condition runs in the family. Testing can look for changes affecting the UBE3A gene and help confirm the cause.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they reveal depends on the condition and the kind of variant involved. Over time, how the body works is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same medication works well for one person, does little for another, or causes more side effects in someone else. These differences are common and can influence both how effective a treatment is and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics is the study of how differences in genes can affect the way a person responds to medicines. It examines the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body handles it. Understanding this can support treatment choices that are both more informed and more individualized. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the UBE3A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so if you have concerns about side effects, new prescriptions, or changes to treatment, it is best to discuss them with your doctor or pharmacist.
History
The history of the UBE3A gene is closely tied to the story of Angelman syndrome, first described in 1965 by the British doctor Harry Angelman. For years, doctors recognized a shared pattern in affected children, but the genetic cause remained unclear. From these first observations, research expanded steadily. In the late 1980s and 1990s, studies of chromosome 15 showed that the condition often involved a missing or altered maternal copy of this region, helping establish the importance of parent of origin in human genetics. Scientists then identified the UBE3A gene within this area and linked changes in it to Angelman syndrome. This work became a landmark in the study of genomic imprinting, where one parent’s copy of a gene is more active than the other.